YolTech Therapeutics, a clinical-stage gene editing company dedicated to delivering lifelong cures, announced the initiation of a clinical trial for YOLT-204, an investigational therapy for the treatment of transfusion-dependent beta-thalassemia (TDT). TDT is a severe genetic blood disorder where mutations in the beta-globin gene leads to reduced or absence of hemoglobin, a condition where regular […]

NEW YORK, NY / ACCESSWIRE / January 20, 2025 / If you suffered a loss on your Symbotic Inc. (NASDAQ:SYM) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/symbotic-lawsuit-submission-form-2?prid=123996&wire=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call (212)

Report with the AI impact on market trends – The global glass tableware marketsize is estimated to grow by USD 2.24 billion from 2025-2029, according to Technavio. The market is estimated to grow at a CAGR of about3.4% during the forecast period. Advancements in glass production techniquesis driving market growth,with a trend towardsrising popularity of

NEW YORK, Jan. 20, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of Western Asset Management Company mutual fund investors resulting from allegations that Western Asset may have issued materially misleading business information to the investing public. SO WHAT: If you

Partners with Prosper Health introducing “Greater Bay Area Cancer Medical Concierge Service Network” AXA Hong Kong and Macau (“AXA”)announces a partnership with Prosper Health, amember-centric health insurance service providerunder New Frontier Group – one of China'sleadingintegrated private healthcare service institutions, to launch premium cross-border medical support services for eligible AXA customers, to further strengthenthe medical

NEW YORK, NY / ACCESS Newswire / January 20, 2025 / If you suffered a loss on your Visa Inc. (NYSE:V) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/visa-inc-lawsuit-submission-form?prid=123995&wire=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call

NEW YORK, NY / ACCESS Newswire / January 20, 2025 / If you suffered a loss on your Zeta Global Holdings Corp. (NYSE:ZETA) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/zeta-global-holdings-corp-lawsuit-submission-form-2?prid=123994&wire=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com

NEW YORK, NY / ACCESS Newswire / January 20, 2025 / If you suffered a loss on your Warner Bros. Discovery, Inc. (NASDAQ:WBD) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/warner-bros-discovery-lawsuit-submission-form?prid=123993&wire=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com

NEW YORK, NY / ACCESS Newswire / January 20, 2025 / If you suffered a loss on your Pacira BioSciences, Inc. (NASDAQ:PCRX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/pacira-biosciences-inc-lawsuit-submission-form?prid=123992&wire=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or

(NasdaqGM:ENPH), NEW YORK, Jan. 20, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Enphase Energy, Inc. (NASDAQ: ENPH) between April 25, 2023 and October 22, 2024, both dates inclusive (the “Class Period”), of the important February 11, 2025 lead plaintiff deadline. SO WHAT: